Skip Navigation
Skip to contents

J Korean Ophthalmol Soc.  2009 Jul;50(7):1060-1065. 10.3341/jkos.2009.50.7.1060.

Incidence and Characteristics of Acute Endophthalmitis Associated With Intravitreal Injection

Affiliations
  • 1Department of Ophthalmology, School of Medicine, Ewha Woman's University, Seoul, Korea.
  • 2Myung Gok Eye Research Institute, Kim's Eye Hospital, Konyang University, Seoul, Korea. mediceye@kimeye.com
  • 3Department of Ophthalmology, Konyang University College of Medicine, Seoul, Korea.

Abstract

PURPOSE
To evaluate the incidence, causative organism, clinical features, and visual outcomes of acute endophthalmitis following intravitreal injection. METHODS: For all intravitreal triamcinolone acetonide, bevacizumab, and lucentis injections performed in our outpatient clinic between January 2006 and June 2008, the number of injections, indications, type of administered drugs, and method of injection were investigated. The medical records of the patients with acute endoththalmitis were reviewed retrospectively. RESULTS: The total number of intravitreal injections was 10,153. The incidence of acute endophthalmitis for all intravitreal injections was 0.020% (2/10,153) with 0.030% (1/3,383) for the triamcinolone acetonide, 0.015% (1/6,552) for the bevacizumab, and 0.000% (0/218) for the ranibizumab drug injections. Streptococcus species were confirmed in the bacterial culture of two eyes with acute endotphthalmitis. After early vitrectomy and intravitreal antibiotics injection, one eye maintained vision but the other eye developed phthisis. CONCLUSIONS: Although the incidence of acute endophthalmitis following intravitreal injections performed in outpatient clinics is very low, due to the potentially fatal visual outcome after endophthalmitis, careful attention to aseptic injection technique is mandatory.

Keyword

Anti-VEGF; Endophthalmitis

MeSH Terms

Ambulatory Care Facilities
Anti-Bacterial Agents
Antibodies, Monoclonal, Humanized
Endophthalmitis
Eye
Humans
Incidence
Intravitreal Injections
Medical Records
Retrospective Studies
Streptococcus
Triamcinolone Acetonide
Vision, Ocular
Vitrectomy
Bevacizumab
Ranibizumab
Anti-Bacterial Agents
Antibodies, Monoclonal, Humanized
Triamcinolone Acetonide
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr